Male Breast Cancer: Understanding the Biology for Improved Patient Care (NCT01101425)
Clinical and Biological Characterization of Male Breast Cancer: an International EORTC, BIG, TBCRC and NABCG Intergroup Study.
🩺 Plain-English Summary (8th-Grade Level)
Rationale: Gathering medical information and tumor samples from patients with male breast cancer may help doctors learn more about the disease. Purpose retrospective part: to perform a large international retrospective analysis of clinical and biological data of male BC patients treated in the participating centers from 1990 to 2010. Purpose prospective part: to create a registry of men with breast cancer for a period of 30 months (starting early 2014).
Who can join: Review the eligibility criteria below.
Location: University Of Alabama Comprehensive Cancer Center — Birmingham, Alabama
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (93 Sites)
Showing the first 25 of 93 sites.
- University Of Alabama Comprehensive Cancer Center — Birmingham, Alabama
- University Of Alabama Comprehensive Cancer Cente — Birmingham, Alabama
- UCSF University of California San Francisco Medical Center-Mount Zion — San Francisco, California
- Georgetown Lombardi Comprehensive Cancer Center — Washington D.C., District of Columbia
- University of Chicago Medicine — Chicago, Illinois
- Indiana University Medical Center — Indianapolis, Indiana
- Johns Hopkins University CRB1 — Baltimore, Maryland
- Johns Hopkins University — Baltimore, Maryland
- Dana-Farber Cancer Institute — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
- Mayo Clinic — Rochester, Minnesota
- Memorial Sloan-Kettering Cancer Center - Memorial hospital — New York, New York
- Duke University Medical Center — Durham, North Carolina
- Baylor college of Medicine — Houston, Texas
- MD Anderson Cancer Center — Houston, Texas
- Baylor College - Ucop — Houston, Texas
- Fred Hutchison Seattle Cancer Care Alliance — Seattle, Washington
- ZNA Middelheim — Antwerp,
- Cliniques Universitaires Saint-Luc — Brussels,
- CHU St Pierre — Brussels,
- Cliniques Universitaires St. Luc — Brussels,
- Hopital Universitaire Brugmann — Brussels,
- Institut Jules Bordet — Brussels,
- Universitair Ziekenhuis Antwerpen — Edegem,
- Hopital De Jolimont — Haine-Saint-Paul,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer — Anniston, Alabama
- [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer — Los Angeles, California
- Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery — Durham, North Carolina
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) — Palo Alto, California
- A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer — Chicago, Illinois
- ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer — Duarte, California
Explore by condition: All Breast Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.